Syndax Announces Participation at Two Upcoming Investor Conferences

Rhea-AI Summary

Syndax Pharmaceuticals (SNDX) will participate in two upcoming investor conferences, the Guggenheim 6th Annual Biotechnology Conference and the Citi 2024 Virtual Oncology Leadership Summit. The management team will engage in fireside chats on February 8th and February 21st, 2024, respectively. The live webcast of the events can be accessed from the Investor section of the Company's website at www.syndax.com.

WALTHAM, Mass., Feb. 1, 2024 /PRNewswire/ -- Syndax Pharmaceuticals (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that members of its management team will participate in two upcoming investor conferences:

• A fireside chat at the Guggenheim 6th Annual Biotechnology Conference at 10:00 a.m. ET on Thursday, February 8, 2024 in New York, NY.
• A fireside chat at the Citi 2024 Virtual Oncology Leadership Summit at 2:00 p.m. ET on Wednesday, February 21, 2024.

A live webcast of the fireside chats can be accessed from the Investor section of the Company's website at www.syndax.com, where a replay of the events will also be available for a limited time.

About Syndax

Syndax Pharmaceuticals is a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies. Highlights of the Company's pipeline include revumenib, a highly selective inhibitor of the menin–KMT2A binding interaction, and axatilimab, a monoclonal antibody that blocks the colony stimulating factor 1 (CSF-1) receptor. For more information, please visit www.syndax.com or follow the Company on Twitter and LinkedIn.

Syndax Contacts

Sharon Klahre
Syndax Pharmaceuticals, Inc.
sklahre@syndax.com
Tel 781.684.9827

SNDX-G

View original content:https://www.prnewswire.com/news-releases/syndax-announces-participation-at-two-upcoming-investor-conferences-302051306.html

SOURCE Syndax Pharmaceuticals, Inc.

FAQ

When will Syndax Pharmaceuticals participate in the Guggenheim 6th Annual Biotechnology Conference?

Syndax Pharmaceuticals will participate in the Guggenheim 6th Annual Biotechnology Conference at 10:00 a.m. ET on Thursday, February 8, 2024 in New York, NY.

Where can the live webcast of the events be accessed?

The live webcast of the events can be accessed from the Investor section of the Company's website at www.syndax.com.

What is the ticker symbol for Syndax Pharmaceuticals?

The ticker symbol for Syndax Pharmaceuticals is SNDX.